Enfermedad priónica

Referencias

Artículos principales

Prusiner SB. Shattuck lecture: neurodegenerative diseases and prions. N Engl J Med. 2001 May 17;344(20):1516-26.Texto completo  Resumen

Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83.Texto completo  Resumen

Department of Health. Minimise transmission risk of CJD and vCJD in healthcare settings. August 2017. [internet publication].Texto completo

Bouzamondo-Bernstein E, Hopkins SD, Spilman P, et al. The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol. 2004 Aug;63(8):882-99. Resumen

Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011 May 17;76(20):1711-9. Resumen

Josephson SA, Papanastassiou AM, Berger MS, et al. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg. 2007 Jan;106(1):72-5.Texto completo  Resumen

Vernino S, Geschwind MD, Boeve B. Autoimmune encephalopathies. Neurologist. 2007 May;13(3):140-7. Resumen

Geschwind MD, Haman A, Miller BL. Rapidly progressive dementia. Neurol Clin. 2007 Aug;25(3):783-807, vii. Resumen

Artículos de referencia

1. Mastrianni JA, Roos RP. The prion diseases. Semin Neurol. 2000;20(3):337-52. Resumen

2. Will RG, Alperovitch A, Poser S, et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann Neurol. 1998 Jun;43(6):763-7. Resumen

3. Prusiner SB. Shattuck lecture: neurodegenerative diseases and prions. N Engl J Med. 2001 May 17;344(20):1516-26.Texto completo  Resumen

4. Prusiner SB. The prion diseases. Brain Pathol. 1998 Jul;8(3):499-513. Resumen

5. Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83.Texto completo  Resumen

6. Kong Q, Surewicz WK, Petersen RB, et al. Inherited prion diseases. In: Prusiner SB, ed. Prion biology and disease. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2004:673-776.

7. Minikel EV, Vallabh SM, Lek M, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016 Jan 20;8(322):322ra9.Texto completo  Resumen

8. Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66:255-265.Texto completo  Resumen

9. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 2000 Oct 24;55(8):1075-81. Resumen

10. Peden A, McCardle L, Head MW, et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia. 2010 Mar;16(2):296-304. Resumen

11. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000 May;47(5):575-82. Resumen

12. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996 Apr 6;347(9006):921-5. Resumen

13. Heath CA, Cooper SA, Murray K, et al. Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):646-51. Resumen

14. Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006 Sep;129(Pt 9):2278-87.Texto completo  Resumen

15. Panagariya A, Jain RS, Sharma AK. Stroke like presentation of Creutzfeldt Jakob disease: an unusual variant. J Assoc Physicians India. 1999 May;47(5):548-50. Resumen

16. Jacobs DA, Lesser RL, Mourelatos Z, et al. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol. 2001 Jun;21(2):99-102. Resumen

17. Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol. 1999 Jan;56(1):55-61.Texto completo  Resumen

18. Poon MA, Stuckey S, Storey E. MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt- Jakob disease. Neuroradiology. 2001 Sep;43(9):746-9. Resumen

19. Belay ED, Holman RC, Schonberger LB. Creutzfeldt-Jakob disease surveillance and diagnosis. Clin Infect Dis. 2005 Sep 15;41(6):834-6. Resumen

20. Laske C, Gefeller O, Pfahlberg A, et al. The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study. Eur J Epidemiol. 1999 Aug;15(7):631-5. Resumen

21. Will R. Variant Creutzfeldt-Jakob disease. Folia Neuropathol. 2004;42(suppl A):77-83. Resumen

22. Kovács GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005 Nov;118(2):166-74. Resumen

23. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999 Aug;46(2):224-33. Resumen

24. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, et al. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology. 2009 Oct;29(5):625-31. Resumen

25. Peretz D, Supattapone S, Giles K, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol. 2006 Jan;80(1):322-31.Texto completo  Resumen

26. Douet JY, Lacroux C, Aron N, et al. Distribution and quantitative estimates of variant Creutzfeldt-Jakob Disease prions in tissues of clinical and asymptomatic patients. Emerg Infect Dis. 2017 Jun;23(6):946-956.Texto completo  Resumen

27. Department of Health. Minimise transmission risk of CJD and vCJD in healthcare settings. August 2017. [internet publication].Texto completo

28. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature. 1997 Oct 2;389(6650):498-501. Resumen

29. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 2004 Aug 7-13;364(9433):527-9. Resumen

30. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004 Feb 7;363(9407):417-21. Resumen

31. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet. 2006 Dec 9;368(9552):2061-7. Resumen

32. Dorsey K, Zou S, Schonberger LB, et al. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion. 2009 May;49(5):977-84. Resumen

33. Zou S, Fang CT, Schonberger LB. Transfusion transmission of human prion diseases. Transfus Med Rev. 2008 Jan;22(1):58-69. Resumen

34. Goold R, Rabbanian S, Sutton L, et al. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun. 2011;2:281.Texto completo  Resumen

35. Norrby E. Prions and protein-folding diseases. J Intern Med. 2011 Jul;270(1):1-14. Resumen

36. Kretzschmar HA, Ironside JW, DeArmond SJ, et al. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996 Sep;53(9):913-20. Resumen

37. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 1999 Jan 16;353(9148):183-9. Resumen

38. DeArmond SJ, Prusiner SB. Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin Lab Med. 2003 Mar;23(1):1-41. Resumen

39. Freixes M, Rodriguez A, Dalfo E, et al. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging. 2006 Dec;27(12):1807-15. Resumen

40. Bleich S, Kropp S, Degner D, et al. Creutzfeldt-Jakob disease and oxidative stress. Acta Neurol Scand. 2000 May;101(5):332-4. Resumen

41. Minghetti L, Pocchiari M. Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases. Int Rev Neurobiol. 2007;82:265-75. Resumen

42. Bouzamondo-Bernstein E, Hopkins SD, Spilman P, et al. The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol. 2004 Aug;63(8):882-99. Resumen

43. DeArmond SJ, Sanchez H, Yehiely F, et al. Selective neuronal targeting in prion disease. Neuron. 1997 Dec;19(6):1337-48. Resumen

44. Prusiner SB, Groth D, Serban A, et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10608-12.Texto completo  Resumen

45. Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell. 1993 Jul 2;73(7):1339-47. Resumen

46. Sailer A, Bueler H, Fischer M, et al. No propagation of prions in mice devoid of PrP. Cell. 1994 Jul 1;77(7):967-8. Resumen

47. Legname G, Baskakov IV, Nguyen HO, et al. Synthetic mammalian prions. Science. 2004 Jul 30;305(5684):673-6. Resumen

48. Makarava N, Kovacs GG, Bocharova O, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 2010 Feb;119(2):177-87. Resumen

49. Prusiner SB. Detecting mad cow disease. Sci Am. 2004 Jul;291(1):86-93. Resumen

50. UK Health Protection Agency. Variant CJD and plasma products. January 2007. [internet publication].Texto completo

51. Puopolo M, Ladogana A, Vetrugno V, et al. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion. 2011 Jul;51(7):1556-66. Resumen

52. Creutzfeldt-Jakob Disease International Surveillance Network. CJD surveillance data 1993-2013. [internet publication].Texto completo

53. Centers for Disease Control and Prevention. BSE (Bovine spongiform encephalopathy, or mad cow disease). October 2018. http://www.cdc.gov/ [internet publication].Texto completo

54. World Organisation for Animal Health. Number of reported cases of bovine spongiform encephalopathy (BSE) in farmed cattle worldwide* (excluding the United Kingdom). 2017. [internet publication].Texto completo

55. Scott MR, Will R, Ironside J, et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci US. 1999 Dec 21;96(26):15137-42.Texto completo  Resumen

56. Williams ES. Chronic wasting disease. Vet Pathol. 2005 Sep;42(5):530-49. Resumen

57. Waddell L, Greig J, Mascarenhas M, et al. Current evidence on the transmissibility of chronic wasting disease prions to humans: a systematic review. Transbound Emerg Dis. 2017 [Epub ahead of print].Texto completo  Resumen

58. Miller MW, Williams ES. Chronic wasting disease of cervids. Curr Top Microbiol Immunol. 2004;284:193-214. Resumen

59. Angers RC, Browning SR, Seward TS, et al. Prions in skeletal muscles of deer with chronic wasting disease. Science. 2006 Feb 24;311(5764):1117. Resumen

60. Mawhinney S, Pape WJ, Forster JE, et al. Human prion disease and relative risk associated with chronic wasting disease. Emerg Infect Dis. 2006 Oct;12(10):1527-35. Resumen

61. Lewis AM, Yu M, DeArmond SJ, et al. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol. 2006 Feb;63(2):288-90.Texto completo  Resumen

62. National Institute for Health and Care Excellence. Donor breast milk banks: the operation of donor milk bank services. February 2010. [internet publication].Texto completo

63. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1551-62.Texto completo  Resumen

64. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009 Oct;132(Pt 10):2659-68.Texto completo  Resumen

65. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011 May 17;76(20):1711-9. Resumen

66. Groveman BR, Orrú CD1, Hughson AG, et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann Clin Transl Neurol. 2016 Dec 27;4(2):139-144.Texto completo  Resumen

67. Geschwind MD, Jay C. Assessment of rapidly progressive dementias. Concise review related to chapter 362: Alzheimer disease and other primary dementias. In: Braunwald E, Harrison TR, Fauci AS, et al, eds. Harrison's principles of internal medicine. New York, NY: McGraw-Hill; 2001:2391-2398.

68. Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006 Jan 24;66(2):286-7. Resumen

69. Prusiner SB, Bosque PJ. Prion diseases. In: Braunwald E, Harrison TR, Fauci AS, et al, eds. Harrison's principles of internal medicine. New York, NY: McGraw-Hill; 2001:2486-2491.

70. Collins S, McLean CA, Masters CL. Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci. 2001 Sep;8(5):387-97. Resumen

71. Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213-39. Resumen

72. American College of Radiology. ACR appropriateness criteria: movement disorders and neurodegenerative diseases. 2019 [internet publication].Texto completo

73. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004 Aug 10;63(3):443-9. Resumen

74. Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology. 1996 Jun;199(3):793-8. Resumen

75. Collie DA, Sellar RJ, Zeidler M, et al. MRI of Creuztfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol. 2001 Sep;56(9):726-39. Resumen

76. Keohane C. Pulvinar sign on MRI images in variant Creutzfeldt-Jakob disease. Lancet. 2000 Apr 22;355(9213):1384. Resumen

77. Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt- Jakob disease. Lancet. 2000 Apr 22;355(9213):1412-8. Resumen

78. Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004 Nov;56(5):702-8. Resumen

79. Chitravas N, Jung RS, Kofskey DM, et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol. 2011 Sep;70(3):437-44.Texto completo  Resumen

80. Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012 Oct 2;79(14):1499-506.Texto completo  Resumen

81. Tschampa HJ, Neumann M, Zerr I, et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):33-9.Texto completo  Resumen

82. Geschwind M, Haman A, Torres-Chae C, et al. CSF findings in a large United States sporadic CJD cohort. Neurology. 2007;68(suppl 1):A142.

83. Huntington's Disease Society of America. Genetic testing for Huntington’s disease: its relevance and implications. 2003. [internet publication].Texto completo

84. de Priester JA, Jansen GH, de Kruijk JR, et al. New MRI findings in Creutzfeldt-Jakob disease: high signal in the globus pallidus on T1-weighted images. Neuroradiology. 1999 Apr;41(4):265-8. Resumen

85. Satoh J, Kurohara K, Yukitake M, et al. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 1999;41(4):216-25. Resumen

86. Satoh K, Shirabe S, Eguchi H, et al. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol. 2006 Feb;26(1):45-52. Resumen

87. Chapman T, McKeel DW Jr, Morris JC. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000 Nov 14;55(9):1396-7. Resumen

88. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006 Aug 22;67(4):637-43. Resumen

89. Moussavian M, Potolicchio S, Jones R. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med. 1997 Mar 20;336(12):873-4 Resumen

90. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996 Sep 26;335(13):924-30.Texto completo  Resumen

91. Tschampa HJ, Kallenberg K, Urbach H, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 2005 Sep;128(Pt 9):2026-33.Texto completo  Resumen

92. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939-44. Resumen

93. Rabinovici GD, Furst AJ, O'Neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2007 Apr 10;68(15):1205-12. Resumen

94. Haik S, Brandel JP, Sazdovitch V, et al. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology. 2000 Nov 14;55(9):1401-4. Resumen

95. McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9(suppl):417-423. Resumen

96. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27;65(12):1863-72. Resumen

97. Catani M, Piccirilli M, Geloso MC, et al. Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity. Dement Geriatr Cogn Disord. 2004;17(1-2):21-8. Resumen

98. Mackenzie IR, Feldman H. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol. 2004 Jul-Aug;23(4):183-93. Resumen

99. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005 Sep 13;65(5):719-25. Resumen

100. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 Dec;51(6):1546-54. Resumen

101. Avanzino L, Marinelli L, Buccolieri A, et al. Creutzfeldt-Jakob disease presenting as corticobasal degeneration: a neurophysiological study. Neurol Sci. 2006 Jun;27(2):118-21. Resumen

102. Ferro JM. Vasculitis of the central nervous system. J Neurol. 1998 Dec;245(12):766-76. Resumen

103. Moore PM, Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):10-22.Texto completo  Resumen

104. Younger DS, Kass RM. Vasculitis and the nervous system. Historical perspective and overview. Neurol Clin. 1997 Nov;15(4):737-58. Resumen

105. Josephson SA, Papanastassiou AM, Berger MS, et al. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg. 2007 Jan;106(1):72-5.Texto completo  Resumen

106. Vernino S, Geschwind MD, Boeve B. Autoimmune encephalopathies. Neurologist. 2007 May;13(3):140-7. Resumen

107. Dropcho EJ. Paraneoplastic diseases of the nervous system. Curr Treat Options Neurol. 1999 Nov;1(5):417-427. Resumen

108. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000 Jul;123 ( Pt 7):1481-94.Texto completo  Resumen

109. Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007 Sep;13(5):261-71. Resumen

110. Rosenbloom MH, Smith S, Akdal G, et al. Immunologically mediated dementias. Curr Neurol Neurosci Rep. 2009 Sep;9(5):359-67.Texto completo  Resumen

111. Kothbauer-Margreiter I, Sturzenegger M, Komor J, et al. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol. 1996 Aug;243(8):585-93. Resumen

112. Seipelt M, Zerr I, Nau R, et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt- Jakob disease. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):172-6.Texto completo  Resumen

113. Josephs KA, Rubino FA, Dickson DW. Nonvasculitic autoimmune inflammatory meningoencephalitis. Neuropathology. 2004 Jun;24(2):149-52. Resumen

114. Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb;63(2):197-202.Texto completo  Resumen

115. Chong JY, Rowland LP. What's in a NAIM? Hashimoto encephalopathy, steroid-responsive encephalopathy associated with autoimmune thyroiditis, or nonvasculitic autoimmune meningoencephalitis? Arch Neurol. 2006 Feb;63(2):175-6. Resumen

116. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003 Feb;60(2):164-71.Texto completo  Resumen

117. Geschwind MD, Yoon G, Goldman J. Adult-onset genetic disorders involving the frontal lobes. In: Miller BL, Cummings JF, eds. The human frontal lobes: functions and disorders. 2nd ed. New York: Guilford Press; 2007:552-575.

118. Geschwind MD, Haman A, Miller BL. Rapidly progressive dementia. Neurol Clin. 2007 Aug;25(3):783-807, vii. Resumen

119. Cavalier L, Ouahchi K, Kayden HJ, et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet. 1998 Feb;62(2):301-10.Texto completo  Resumen

120. Kitzberger R, Madl C, Ferenci P. Wilson disease. Metab Brain Dis. 2005 Dec;20(4):295-302. Resumen

121. Ross ME, Jacobson IM, Dienstag JL, et al. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol. 1985 Apr;17(4):411-3. Resumen

122. Molina JA, Jimenez-Jimenez FJ, Calandre L. Bismuth encephalopathy. Neurology. 1994 Mar;44(3 Pt 1):582. Resumen

123. Teepker M, Hamer HM, Knake S, et al. Myoclonic encephalopathy caused by chronic bismuth abuse. Epileptic Disord. 2002 Dec;4(4):229-33. Resumen

124. Jungreis AC, Schaumburg HH. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurology. 1993 Jun;43(6):1265. Resumen

125. Le Quesne PM. Metal-induced diseases of the nervous system. Br J Hosp Med. 1982 Nov;28(5):534-8. Resumen

126. Timmermans M, Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1727-30.Texto completo  Resumen

127. Fallon BA, Nields JA, Parsons B, et al. Psychiatric manifestations of Lyme borreliosis. J Clin Psychiatry. 1993 Jul;54(7):263-8. Resumen

128. Kaplan RF, Jones-Woodward L. Lyme encephalopathy: a neuropsychological perspective. Semin Neurol. 1997 Mar;17(1):31-7. Resumen

129. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008 Mar 25;70(13):992-1003. Resumen

130. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990 Nov 22;323(21):1438-44. Resumen

131. Louis ED, Lynch T, Kaufmann P, et al. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol. 1996 Oct;40(4):561-8. Resumen

132. Ghezzi A, Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci. 2001 Nov;22 Suppl 2:S117-22. Resumen

133. Durand DV, Lecomte C, Cathebras P, et al. Whipple disease: clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore). 1997 May;76(3):170-84. Resumen

134. Zoonotic Disease Division of Emerging and other Communicable Diseases Surveillance and Control. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. Geneva, Switzerland: WHO; 1998.Texto completo

135. Shaked GM, Engelstein R, Avraham I, et al. Valproic acid treatment results in increased accumulation of prion proteins. Ann Neurol. 2002 Oct;52(4):416-20. Resumen

136. Sander JW, Duncan JS. Valproic acid and prion proteins. Ann Neurol. 2003 May;53(5):688-9. Resumen

137. Spencer MD, Knight RS, Will RG. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ. 2002 Jun 22;324(7352):1479-82.Texto completo  Resumen

138. Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013 Oct 15;347:f5675.Texto completo  Resumen

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad